RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields

NCT ID: NCT01839162

Last Updated: 2016-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

452 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During percutaneous coronary interventions standard operator radio-protection is generally ensured using a lead apron, a thyroid lead collar, low leaded flaps, an upper mobile leaded glass suspended from the ceiling and leaded glasses. Previous studies showed that adding a bismuth-barium radiation shield drape on the patient right arm or using a pelvic lead shield on the patient, the radiation dose adsorbed by operators was significantly reduced even if was higher compared to transfemoral approach. No studies evaluated the effect of both adjunctive shields placed in the same patient.

Aim of our randomized study is to evaluate if the combination of a shield drape on the patient right arm and a pelvic lead shield during transradial percutaneous coronary procedures may reduce the radiation dose adsorbed by operators compared to the use of only one shield or none.

All patients who underwent to percutaneous coronary diagnostic or interventional procedures will be enrolled in this randomized study. Eligible patients will be randomized (using a computer generated randomization sequence) in 4 groups:

1. use of a pelvic shield drape
2. use of a shield drape on the patient right arm
3. use of a pelvic shield drape and a shield drape on the patient right arm
4. Any adjunctive shield drape (only standard radio-protection) For each group a further internal randomization will be performed in order to compare the right or left radial transradial approach.

Each operator will be equipped with dedicated dosimeters placed at left wrist and at thorax level outside the lead apron. Since December 2013 the operators are equipped with a further dosimeter at head level.

Primary end-point of the study is the radiation dose adsorbed at wrist and thorax by operators and detected by the electronic dosimeters.

Secondary end-point are:

1. Radiation dose adsorbed by operators according to the radial access (right versus left)
2. Radiation dose adsorbed by the patients
3. Radiation dose adsorbed at head level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pelvic drape

Pelvic shield drape over the patient

Group Type EXPERIMENTAL

Coronary angiography

Intervention Type PROCEDURE

Diagnostic coronary angiography

PCI

Intervention Type PROCEDURE

Percutaneous coronary intervention

Right approach

Intervention Type PROCEDURE

Right transradial access

Left approach

Intervention Type PROCEDURE

Left transradial access

Arm drape

Right radial arm drape over the patient

Group Type EXPERIMENTAL

Coronary angiography

Intervention Type PROCEDURE

Diagnostic coronary angiography

PCI

Intervention Type PROCEDURE

Percutaneous coronary intervention

Right approach

Intervention Type PROCEDURE

Right transradial access

Left approach

Intervention Type PROCEDURE

Left transradial access

Pelvic and arm drape

Pelvic and arm drpaes placed over the patient

Group Type EXPERIMENTAL

Coronary angiography

Intervention Type PROCEDURE

Diagnostic coronary angiography

PCI

Intervention Type PROCEDURE

Percutaneous coronary intervention

Right approach

Intervention Type PROCEDURE

Right transradial access

Left approach

Intervention Type PROCEDURE

Left transradial access

No drapes

Standard radioprotection devices

Group Type SHAM_COMPARATOR

Coronary angiography

Intervention Type PROCEDURE

Diagnostic coronary angiography

PCI

Intervention Type PROCEDURE

Percutaneous coronary intervention

Right approach

Intervention Type PROCEDURE

Right transradial access

Left approach

Intervention Type PROCEDURE

Left transradial access

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coronary angiography

Diagnostic coronary angiography

Intervention Type PROCEDURE

PCI

Percutaneous coronary intervention

Intervention Type PROCEDURE

Right approach

Right transradial access

Intervention Type PROCEDURE

Left approach

Left transradial access

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients who underwent to percutaneous coronary diagnostic or interventional procedures will be enrolled in this randomized study

Exclusion Criteria

1. Previous coronary artery by-pass
2. Acute ST elevation myocardial infarction
3. Hemodynamic instability or cardiogenic shock
4. Ischemic Allen test.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ospedale Sandro Pertini, Roma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alessandro Sciahbasi, MD

Interventional Cardiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale Sandro Pertini - ASL RMB- UOSD Emodinamica

Rome, Rome, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ASLRMB-Pertini1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.